TW201034681A - Process for the preparation of lactic- and phenyllactic-acid-containing, optically active, cyclic depsipeptides with 24 ring atoms with the aid of fungal strains of Rosellinia species and further Xylariaceae - Google Patents

Process for the preparation of lactic- and phenyllactic-acid-containing, optically active, cyclic depsipeptides with 24 ring atoms with the aid of fungal strains of Rosellinia species and further Xylariaceae Download PDF

Info

Publication number
TW201034681A
TW201034681A TW098143185A TW98143185A TW201034681A TW 201034681 A TW201034681 A TW 201034681A TW 098143185 A TW098143185 A TW 098143185A TW 98143185 A TW98143185 A TW 98143185A TW 201034681 A TW201034681 A TW 201034681A
Authority
TW
Taiwan
Prior art keywords
fungal strains
genus
optically active
charcoal
xylariaceae
Prior art date
Application number
TW098143185A
Other languages
English (en)
Inventor
Achim Harder
Thi Lam Huong Pham
Rene Jarling
Irmtraut Zaspel
Dietrich Ewald
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of TW201034681A publication Critical patent/TW201034681A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

201034681 六、發明說明: 【發明所屬技術領域】 本發明係關於—錄制&入> 個環原子的光學活性P : 3魏及苯基乳酸之具有24 之方法,其係藉由 或以這些真菌菌株所分離:音:厌角菌科之真菌菌株’ 之m〇22M顯著的^ 物而得。具有通式⑴ 醫學領域。 的適於抑制内寄生蟲,尤其在醫學及獸
本發明係關於一種製備含乳酸及苯基乳酸之具有24 個環原子的環狀縮紛酸肽類之新方法,上述具有24個環 原子的環狀縮紛酸肽類(八縮盼酸肽類 (octadepsipeptides))及其殺内寄生蟲劑之應用已經是先前 專利申請案(US005571793A)的主題,有一系列的化學 201034681 及微生物學方法以製備含D-2-經基異戍酸之具有24個環原 子的環狀縮紛酸肽類(例如:合成法,參照Ohyama M. et al” Biosci.Biotechnol. Biochem. 58 (1994) pp.1193-1194; Scherkenbeck J.Et al. Tetrahedron 51 (1995) pp. 8459-8470;
Kobayashi M. et al. Annu. Rep. Sankyo Res. Lab. 46 (1994) pp. 67-75; Lee B. et al. Bioorg. Med. Chem. Lett. 12 (2002) pp. 353-356; Dutton FE et al. J.Antibiot. 47 (1994) pp. 1322-1327)。 曰本專利(Sasaki T et al. J. Antibiot. 45 (1992) pp. 692-697; Yanai K et al. Nature Biotechnology 22 (2004) pp. 848-855)說明由真菌菌株幫助含D-乳酸及D-苯基乳酸的 環狀八縮紛酸肽PF1022A之發酵,該真菌菌株已被稱為 “PF1022A菌株”。PF1022A菌株分離自收集於日本茨城 縣(Ibaraki Prefektur)之山茶花植物 葉,該菌株以寄存編號FERMBP-2671寄存於日本國立生 物科學與人類科技研究所工業科學與科技署(National Institute of Bioscience and Human Technology, Agency of Industrial Science and Technology),及以寄存編號 No. IF03 3 096 寄存於大阪發酵學會(institute for Fermentation, Osaka)。由 Meiji Saika Kaisha 有限公司說明之 PF1022A 生產真菌菌株屬於炭角菌科,其最近親緣為白羽紋病菌 (Rosellinia necatrix) IFO 32537 ( Miyadoh S. et al.
Nippon Kingakukai Kaiho 41 (2000), pp. 183-188)及炭角 菌IFO9780 ( Sasaki T et al. J. 5 201034681
Antibiot. 45 (1992),pp 692-697),此兩菌株不會產生任何 PF1022A化合物。 【發明内容】 本發明係關於新真菌菌株之發現,該類真菌菌株分 離自生長於落葉及針葉樹之枯木的座間殼菌種之子實= 及其他炭角菌科,以用於製造PF1022A。 由生長於落葉及針葉樹之枯木的座間殼菌種之子實體及 其他炭角菌科的真菌菌株以做為PF1022A潛在活性物質f 形成者之分離說明: 普遍存在的座間殼菌屬歸類於炭角菌科,該科歸於 廣泛的炭角菌目(子囊菌門),此目之典型特徵為具有輪 廓分明小孔之球形子實體(子囊殼(perithecia)),含有抱子 之子囊在此發育。 除座間殼菌屬外’其他褐瘤菌屬(Daldinia)、黑瘤孽 屬(Hypoxylon)、孢子菌屬(proronia)、茶樹黑瘤病菌屬 (Ustulina)及木材菌屬(Xylaria)均歸類於此科。上述每—屬 有一系列可能產生環狀縮酚酸肽類之不同的種。 炭角菌科具有非常堅硬易脆的子囊殼,每一殼八個 棕色至黑色之孢子的子囊位於子囊殼中。座間殼菌屬包括 一系列腐生或内寄生,並且證實為病原體的種,病原種寄 生於落葉與針葉樹之活木材及根系中,該屬之典型腐生種 主要生長於已分解的朽木。在自然環境中,特有的種對溫 度、濕度及光線有相當高的需求,其生長同時與季節(特 6 201034681 別為冬末春初)和高度不受干擾的群落小區有關。可在受 少許影響(若有的話)的森林發現座間殼菌。 、由枯死之落葉林樣本(例如:懸鈴木、刺槐)分離 感興趣之座間殼8真菌ϋ株;然而,由於不同分解程度, 個別枯死木材樣本的樹木麵之屬性無法永遠精核。 由枯木材移出的成熟、完整、分離(如有可能)之 =囊殼得到祕培養物。以濃度G祕贿液表面消 毒並反覆以無菌水沖洗,小心以顯微鏡玻片壓碎子囊殼, 釋出之子囊及孢子移入含無菌水的試管中。 以顯微鏡觀察可能估計孢子的密度與成熟程度;至 於咼孢子岔度,十倍數稀釋孢子懸浮液,每一稀釋步驟取 100微升平板塗佈至麥芽萃取物瓊脂培養基(mea),該 培養基平板存放於18至2〇。(:,於顯微鏡下每日記錄,並 且將發芽孢子移至新鮮馬鈴薯葡萄糖壤脂培養基 (PDA),於該培養基形成之菌絲體呈白色淺細長構造, 不形成氣生菌絲體。 培養物充分生長之後,遵照標準方法以甲醇萃取菌 絲體,以液相層析-光電二極體陣列-電離-四極飛行式 質讀儀(LC-PDA-ESI-Q-TOF_MS )及串聯式質譜儀 (MS/MS)鑑定菌絲體萃取物之成分及定量PF1022A之 含量’發現不同座間殼菌品系’這些品系被證實與形成 PF1022A 有關。 依據形態特徵,六種PF1022A產生者被認定為下列種類: Ja9 洛葉林之附抱座間殼菌()(無法進 7 201034681 一步詳細測定)
Jal5=來自於懸龄木之附抱座間殼菌(及叫w//a) Jal6=來自於落葉林之座間殼菌屬(如北)(無法 進一步詳細測定)
Jal9 =來自於刺槐或懸鈴木之附孢座間殼菌或克堤昆座 間殼菌(/?. corhcww )
Ja21 -洛葉林之克堤昆座間殼菌(無法進一步詳細測定) Ja26=落葉林之座間殼菌屬(無法進一步詳細測定) 進行培養貫驗’與無抱菌T38-18 (il^yce/ί'α T38-18) 野生型、艾司康狄塔座間殼菌(及⑽e//z_m'a ahc⑽而β)菌株CBS 448.89及CBS 450.89比較,新分離 之真菌菌株於MEA、mPDA、CMA培養基及種子培養基 (seed agar)上顯示生長較快。 生長於21至22°C,10至12天之附孢座間殼菌Ja-9、 附孢座間殼菌Ja-15與座間殼菌屬ja_i6培養物可生長至 培養皿的邊緣(9公分),而對照的培養物無孢菌丁38_18 “野生型”、艾司康狄塔座間殼菌CBS 448.89及艾司康狄塔 座間殼菌CBS 450.89卻顯著的以較短的直徑為特色,這 表示新的座間殼菌菌株特色為生長較快;菌株附孢座間殼 菌或克堤昆座間殼菌Ja-19、克堤昆座間殼菌ja_21及座間 殼菌屬Ja-26生長同樣快。 細長之il絲體生長於MEA及mPDA培養基,而緻 密而纏結(在某些情況下)之菌絲體形成於高營養培養基 201034681 CMA及種子培養基。於M1培養基上分離株仏_19與以_加 形成外觀部分似羽毛的菌絲體。 使用培養基之成分: CMA .玉米粉50公克/公升,瓊脂15公克/公升 M1 ·麥芽萃取物10公克/公升,酵母菌萃取物4公克/公 升,葡萄糖4公克/公升,瓊脂15公克/公升
Seedagar .藥培養基(pharmamedia) 20公克/公升,大豆 蛋白脒2克/公升,麥芽糖40克/公升及七結晶 水硫酸鎂2克/公升,氯化鈉2克/公升,碳^ 鈣3克/公升,瓊脂15公克/公升 MEA:麥芽萃取物17公克/公升,瓊脂15公克/公升 mPDA .葡萄糖5公克/公升,馬鈴薯澱粉2〇公克/公升, 酵母菌萃取物1.5公克/公升,瓊脂15公克/公升 由於目前之培養物是直接由自然生態系移至人工環 境之分離株,可能產生形成不同菌絲體形狀與關於形成不 同程度的活性物質之栽培品種。 【實施方式】 9 201034681 以LC-PDA-ESI-Q_TOF-MS及MS/MS鑑定新分離菌株之 菌絲體萃取物的成分(特別是PF1022A)與無孢菌T38-18 · 野生型比較之說明: 為了鑑定組成成分(特別是PF1022A化合物),使 用一種摘測器、光電二極體陣列(photodiode array ; PDA ) 及質譜儀(MS)兩偵測儀之高效液相層析法(HPLC)研 究無孢菌T38-18野生型與新分離株ja-9、Ja-15、Ja-16、 Ja-19、ja-21與Ja-26之曱醇菌絲體萃取物。 藉由光電二極體陣列及質譜儀偵測之高效液相層析ί》 法’該研究可比較無孢菌Τ38-18野生型與新分離株Ja-21 的甲醇菌絲體萃取物之成分,顯示上述品種的產生成分之 明顯差異如下: 無孢菌野生塑產生一系列PF1022化合物:PF1022-A (C52H76N4012)、PF1022-B ( C64H84N4012)、PF1022-C (C58H8〇N4〇i2 ) ' PF1022-D ( C46H72N4012 ) > PF1022-E (C52H76N4〇13)及 PF1022-F (C49H68N4012);除了新分離 株之外(例如Ja-21) ’這些化合物以PF1022-A (於光電U -~極體陣列及質譜儀 <貞測之層析圖的滞留時間(retention time ; Rt) : 25.1 至 25.6 分鐘)與 PH022-D (滯留時間: 19·5至20分鐘)為主要成分。 PF1022-A (以液相層析光電二極體陣列質譜儀 (LC-PDA-MS )加上紫外光/可見光(UV/V)與質譜儀數據 及滯留時間定性,與無孢菌之PF1022A相較,具有在高效 液相層析圖的相同滯留時間之同一分子量)與其他不屬於 201034681 主要成分PF1022之化合物(滯留時間:12 么至24分鐘) 也產生PF1022-B及-C為次級化合物,但實際上沒有 PF1022-D ;也未發現化合物PF1022-E及-F。、^ 比較無抱菌野生型與新分離株以_15及;^9之總離 子層析質諸圖(TIC-MS)也發現相同結果;以液相芦析_ 光電二極體陣列-電離-四極飛行式質譜儀及串聯^質譜 儀對PF1022A化合物進行進一步鑑識研究。 ”貝°曰 也比較無孢菌野生型與新分離株ja_15及Ja_l9之菌 絲體萃取物的PF1022A化合物於液相層析串聯式質 (LC-MS/MS)層析圖的選取尖峰’這些尖峰有相同^留 時間,於串聯式質譜儀偵測之無孢菌野生型與新分離株 Ja-15及Ja-19菌絲體萃取物之PF1022A化合物的質量 949.6之質子加合物串聯式質譜儀片段彼此相同。 上述液相層析-光電二極體陣列-電離—四極飛行 式質譜儀及串聯式質譜儀之研究結果證實新分離株如
Ja-15、Ja-19 及 Ja-21 也與 Ja-9、Ja-16 及 Ja_26 並非無 孢菌野生型,但也產生PF1022A化合物。 與無孢菌野生型相較,由於新的座間殼菌與木材菌 品種不產生次級化合物PF1022-D、-E及-F,萃取及分離 PFl〇22A方法極其簡單。 【圖式簡單說明】 【主要元件符號說明】 % 11

Claims (1)

  1. 201034681 七、申請專利範圍: 1. 一種製備具下式之PF1022A之方法,其係為具有24個環原ί 子的環狀縮酚酸肽類,該方法係藉由座間殼菌種及炭角菌' 科的其他屬之真菌菌株,或藉由這些真菌菌株所分離之酵-素製備物之輔助而得
    2.根據申請專利範圍第1項之製備PF1022A之方法,其係藉 由座間殼菌及其他炭角菌科之真菌菌株,特別是附孢座間 殼菌()或克堤昆座間殼菌( coh/cwm)之輔助而得。 12 201034681 四、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件符號簡單說明: 無
    五、本案若有化學式時,請揭示最能顯示發明特徵的化 學式: 201034681 發明鼻利說明書
    (本說明書格式 ,請勿任意更動’※記號部分請勿填寫) 分類: I ※申請案號:/4$( ※申請曰:u Jt \> 一、發明名稱:(中文/英文) 以座間殼菌及其他炭角菌科之真菌菌株製備含乳酸及苯基 乳酸之具有24個環原子的光學活性環狀縮盼酸肽類 (depsipeptides)之方法 Process for the preparation of lactic- and phenyllactic-acid-containing, optically active, cyclic depsipeptides with 24 ring atoms with the aid of fungal strains of Rosellinia species and further Xylariaceae 二、中文發明摘要: 學及獸醫學領域。 本發明係關於一種製備含乳酸及苯基乳酸之具有24 個%原子的光學活性環狀縮酚酸肽類之方法,其藉由座間 殼菌及其他炭錢科之真難株,或藉由這些真g菌株所 分離之酵素製備物而得,賴真Kg株不但可由生長於落 葉與針葉樹之枯死及活木材的座間㈣種及炭角菌之子實 體分離,射直接由落葉與針葉狀木材與根分離。具有 通式(I)之PFIGUA係顯著的適於抑制内寄生蟲,尤其在醫 201034681 發明鼻利說明書
    (本說明書格式 ,請勿任意更動’※記號部分請勿填寫) 分類: I ※申請案號:/4$( ※申請曰:u Jt \> 一、發明名稱:(中文/英文) 以座間殼菌及其他炭角菌科之真菌菌株製備含乳酸及苯基 乳酸之具有24個環原子的光學活性環狀縮盼酸肽類 (depsipeptides)之方法 Process for the preparation of lactic- and phenyllactic-acid-containing, optically active, cyclic depsipeptides with 24 ring atoms with the aid of fungal strains of Rosellinia species and further Xylariaceae 二、中文發明摘要: 學及獸醫學領域。 本發明係關於一種製備含乳酸及苯基乳酸之具有24 個%原子的光學活性環狀縮酚酸肽類之方法,其藉由座間 殼菌及其他炭錢科之真難株,或藉由這些真g菌株所 分離之酵素製備物而得,賴真Kg株不但可由生長於落 葉與針葉樹之枯死及活木材的座間㈣種及炭角菌之子實 體分離,射直接由落葉與針葉狀木材與根分離。具有 通式(I)之PFIGUA係顯著的適於抑制内寄生蟲,尤其在醫 201034681 三、英文發明摘要: The present invention relates to a process for the preparation of lactic- and phenyllactic-acid-containing, optically active, cyclic depsipeptides with the 24 ring atoms by means of fungal strains of the genus Rosellinia and further Xylariaceae isolated not only from fruiting bodies of Rosellinia spp. and Xylariaceae growing on dead timber and live timber of deciduous and coniferous trees, but also directly from timber and roots of deciduous and coniferous trees, or by means of enzymatic preparations isolated from these fungal strains. PF1022A, of the general formula (I), is outstanding suitable for controlling endoparasites, in particular in the field of medicine and veterinary medicine. 2
TW098143185A 2008-12-16 2009-12-16 Process for the preparation of lactic- and phenyllactic-acid-containing, optically active, cyclic depsipeptides with 24 ring atoms with the aid of fungal strains of Rosellinia species and further Xylariaceae TW201034681A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08021792 2008-12-16

Publications (1)

Publication Number Publication Date
TW201034681A true TW201034681A (en) 2010-10-01

Family

ID=41510713

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098143185A TW201034681A (en) 2008-12-16 2009-12-16 Process for the preparation of lactic- and phenyllactic-acid-containing, optically active, cyclic depsipeptides with 24 ring atoms with the aid of fungal strains of Rosellinia species and further Xylariaceae

Country Status (20)

Country Link
US (1) US20110262969A1 (zh)
EP (1) EP2379731A1 (zh)
KR (1) KR20110095350A (zh)
CN (1) CN102257154A (zh)
AR (1) AR074673A1 (zh)
AU (1) AU2009331930A1 (zh)
BR (1) BRPI0922388A2 (zh)
CA (1) CA2746733A1 (zh)
CO (1) CO6362018A2 (zh)
CR (1) CR20110325A (zh)
DO (1) DOP2011000182A (zh)
EC (1) ECSP11011117A (zh)
IL (1) IL213006A0 (zh)
MX (1) MX2011006140A (zh)
RU (1) RU2011129395A (zh)
SV (1) SV2011003943A (zh)
TW (1) TW201034681A (zh)
UY (1) UY32322A (zh)
WO (1) WO2010072323A1 (zh)
ZA (1) ZA201104410B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010329998B2 (en) * 2009-12-11 2015-05-21 Bayer Intellectual Property Gmbh Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides
AU2016380868B2 (en) 2015-12-28 2019-11-28 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
CN108570016B (zh) * 2017-03-10 2021-11-26 上海医药工业研究院 一种pf1022a分离纯化的方法
WO2018166899A1 (en) 2017-03-14 2018-09-20 Acidophil Ltd Methods for production of pf1022a derivatives
CN109880746B (zh) * 2017-12-06 2023-10-20 海正药业(杭州)有限公司 一种座坚壳属真菌菌株及其应用
WO2020018888A1 (en) 2018-07-20 2020-01-23 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
CN110964646B (zh) * 2019-11-15 2021-07-27 成都大学 一种座坚壳菌、应用、发酵培养基及pf1022a的制备方法
CN115247132B (zh) * 2021-04-26 2024-04-16 中国科学院微生物研究所 一种组合型人工生物结皮治理荒漠的方法
CN114084497B (zh) * 2021-10-25 2023-05-05 中国热带农业科学院海口实验站 一种果蔬保鲜袋及其制备方法与应用
CN114875093B (zh) * 2022-05-20 2024-07-19 浙江海正药业股份有限公司 一种提高pf1022a发酵产量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000029822A (ko) * 1996-08-07 2000-05-25 이치로 키타사토 환상데프시펩티드화합물의제조방법과새로운환상데프시펩티드

Also Published As

Publication number Publication date
UY32322A (es) 2010-07-30
ECSP11011117A (es) 2011-07-29
KR20110095350A (ko) 2011-08-24
AR074673A1 (es) 2011-02-02
US20110262969A1 (en) 2011-10-27
EP2379731A1 (de) 2011-10-26
RU2011129395A (ru) 2013-01-27
ZA201104410B (en) 2012-09-26
DOP2011000182A (es) 2011-07-15
AU2009331930A1 (en) 2011-06-30
MX2011006140A (es) 2011-08-03
BRPI0922388A2 (pt) 2019-09-24
CO6362018A2 (es) 2012-01-20
SV2011003943A (es) 2011-11-08
CN102257154A (zh) 2011-11-23
CR20110325A (es) 2011-09-29
IL213006A0 (en) 2011-07-31
WO2010072323A1 (de) 2010-07-01
CA2746733A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
TW201034681A (en) Process for the preparation of lactic- and phenyllactic-acid-containing, optically active, cyclic depsipeptides with 24 ring atoms with the aid of fungal strains of Rosellinia species and further Xylariaceae
Mohamed et al. Isolation and characterization of actinobacteria from Algerian Sahara soils with antimicrobial activities
Xu et al. Fusarium fruiting body microbiome member Pantoea agglomerans inhibits fungal pathogenesis by targeting lipid rafts
Bills et al. Hypoxylon pulicicidum sp. nov.(Ascomycota, Xylariales), a pantropical insecticide-producing endophyte
Kossuga et al. Evaluating methods for the isolation of marine-derived fungal strains and production of bioactive secondary metabolites
Garcia et al. Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods
Savi et al. Microbispora sp. LGMB259 endophytic actinomycete isolated from Vochysia divergens (Pantanal, Brazil) producing β-carbolines and indoles with biological activity
Peng et al. Insights into Streptomyces spp. isolated from the rhizospheric soil of Panax notoginseng: isolation, antimicrobial activity and biosynthetic potential for polyketides and non-ribosomal peptides
Yu et al. Phylogenetically diverse endozoic fungi in the South China Sea sponges and their potential in synthesizing bioactive natural products suggested by PKS gene and cytotoxic activity analysis
US20120302496A1 (en) Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides
Boudjeko et al. Streptomyces cameroonensis sp. nov., a geldanamycin producer that promotes Theobroma cacao growth
Lahoum et al. Antifungal activity of a Saharan strain of Actinomadura sp. ACD1 against toxigenic fungi and other pathogenic microorganisms
Gaspari et al. Myxobacteria isolated in Israel as potential source of new anti‐infectives
CN115197172A (zh) 二倍半萜化合物、其合成基因簇与合成方法
Tanvir et al. Screening of endophytic Streptomycetes isolated from Parthenium hysterophorus L. against nosocomial pathogens
Kim et al. Identification of antifungal niphimycin from Streptomyces sp. KP 6107 by screening based on adenylate kinase assay
JP5826406B2 (ja) ストレプトマイセス、抗腫瘍化合物スピロインディマイシン(Spiro−Indimycin)A−D、その製造方法及び使用、並びに、該スピロインディマイシンを含む抗腫瘍剤及び薬物
Kumar et al. Cultural, morphological and molecular characterization of vinca alkaloids producing endophytic fungus Fusarium solani isolated from Catharanthus roseus
CN109280034B (zh) 一种具有抑菌活性的苯并氮氧杂卓类化合物及其制备方法与应用
CN108085273B (zh) 一株抗真菌链霉菌及其代谢物、代谢物制备方法与应用
Kumar et al. Isolation, purification and partial characterization of an antibacterial agent produced by halotolerant alkaliphilic Streptomyces sp. EWC 7 (2)
Mishra et al. Phylogenetic diversity and antioxidant activity of selected fungi from ethno-medicinal plants and soil
Kuncharoen et al. Characterisation of two polyketides from Streptomyces sp. SKH1-2 isolated from roots of Musa (ABB) cv.‘Kluai Sao Kratuep Ho’
Tazik et al. LC-MS based identification of stylosin and tschimgine from fungal endophytes associated with Ferula ovina
Mincer et al. Phylogenetic analyses and diterpenoid production by marine bacteria of the genus Saprospira